This observed effect appeared comparable to that observed in a control group of obese patients without MC4R variants, with the weight loss predominantly attributed to fat mass and minimal impact noted on lean body mass
Compounded drugs arent FDA-approved
Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H, et al
Restaurants: Restaurants, in particular quick-service and fast-food restaurants could also be impacted by changes in eating habits and consumption
However, Lilly recently (April 21, 2023) registered a new Phase 3b trial (SURMOUNT-5) that will compare Mounjaro against Wegovy in patients with obesity or overweight with weight-related health conditions